Dr. Hannah has decades of oncology drug development experience and has served on Rigel's Board of Directors since 2021She has resigned from Rigel's Board of Directors to join the company ... .
Physician-scientist and healthcare analytics leader joins NCQA to advance digital quality measurement, data-driven innovation and patient-centered outcomes ....
Veteran clinical enterprise leader brings 23 years of practice and a six-location care network to the company, building the TrustLayer for AI in healthcare ... .
Brings more than 25 years of global drug development, regulatory and strategic leadership experience successfully guiding innovative therapies from clinical development through regulatory approval and commercialization ... .
Favit-Van Pelt transitions to Bioness from her former role of Chief Medical Officer of Helius Medical Inc, the manufacturer of the Portable ... Favit-Van Pelt, Bioness Chief Medical Officer.
This week, ChristinaDavidson, MD, FACOG, a nationally recognized academic leader and board-certified maternal-fetal medicine specialist, joined ACOG as its new chief medical officer.
Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical OfficerPress release... Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer.
Fockler, DO, Chief Medical Officer... Fockler, DO, as the organization's new Chief Medical Officer (CMO) ... Medical Officer ... As Chief Medical Officer, Dr ... chief medical officer CMO Craig Fockler CSSMCW Dr.
Tamika Lasege as the new chief medical officer (CMO) for CareSource Georgia... Previous roles include serving as the CMO at UnitedHealthcare in Georgia and, most recently, as the Georgia market medical ...